SCHEMBL1825458

SCHEMBL1825458

CC(O)c1cccc(OS(=O)(=O)c2ccccc2)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
ADRB3 P13945 1/20 0.47
TDP1 Q9NUW8 3/20 0.45
PTGS1 P23219 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
MAOB P27338 2/20 0.43
ADAMTS4 O75173 1/20 0.42
MAPT P10636 1/20 0.41
F2 P00734 1/20 0.41
UGT2B7 P16662 1/20 0.41
GAA P10253 1/20 0.40
MAPK1 P28482 1/20 0.40
MEN1 O00255 1/20 0.40
CYP2D6 P10635 1/20 0.40
KMT2A Q03164 1/20 0.40
GPR17 Q13304 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1823209 0.88 MEN1 (0.50) ALDH1A1SMN1; SMN2TDP1L3MBTL1LMNA
SCHEMBL2834837 0.85 PTGS1 (0.64) ALDH1A1SMN1; SMN2ADRB3TDP1PTGS1
SCHEMBL1823779 0.84 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2ADRB3TDP1PTGS1
SCHEMBL1824648 0.84 PTGS1 (0.55) ALDH1A1SMN1; SMN2ADRB3TDP1PTGS1
SCHEMBL1825480 0.84 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2ADRB3TDP1PTGS1
SCHEMBL1825347 0.84 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2ADRB3TDP1PTGS1
SCHEMBL1828838 0.83 PTGS1 (0.50) ALDH1A1SMN1; SMN2ADRB3TDP1PTGS1
SCHEMBL1825604 0.83 TDP1 (0.57) ALDH1A1SMN1; SMN2TDP1L3MBTL1LMNA
SCHEMBL1821446 0.82 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2ADRB3TDP1PTGS1
SCHEMBL2839041 0.82 PTGS1 (0.56) ALDH1A1SMN1; SMN2ADRB3TDP1PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 ALDH1A1 1099/4885SMN1; SMN2 2274/4885ADRB3 1280/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 ALDH1A1 1440/4885SMN1; SMN2 3216/4885ADRB3 1134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.